This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
severe acute respiratory | 202 |
infectious bronchitis virus | 200 |
as well as | 199 |
acute respiratory syndrome | 195 |
the use of | 157 |
respiratory syndrome coronavirus | 150 |
the presence of | 143 |
the development of | 137 |
in this study | 136 |
cd t cells | 131 |
west nile virus | 116 |
based on the | 115 |
in order to | 114 |
respiratory syncytial virus | 109 |
of the vaccine | 109 |
the number of | 101 |
due to the | 98 |
of the virus | 97 |
one of the | 95 |
balb c mice | 92 |
a number of | 90 |
the united states | 89 |
compared to the | 87 |
data not shown | 87 |
in the united | 86 |
middle east respiratory | 85 |
east respiratory syndrome | 85 |
cd t cell | 82 |
shown in fig | 81 |
as shown in | 80 |
been shown to | 77 |
t cell responses | 76 |
a and b | 75 |
according to the | 75 |
avian infectious bronchitis | 73 |
cd and cd | 72 |
in the us | 71 |
rift valley fever | 71 |
and immunogenicity of | 70 |
a total of | 68 |
h n vaccine | 67 |
cellular immune responses | 66 |
the absence of | 66 |
the s protein | 65 |
the role of | 63 |
years of age | 63 |
the risk of | 62 |
in addition to | 61 |
vesicular stomatitis virus | 60 |
safety and immunogenicity | 60 |
to determine the | 59 |
of infectious bronchitis | 59 |
for h at | 58 |
development of a | 58 |
morbidity and mortality | 58 |
was used to | 58 |
and respiratory syndrome | 58 |
the frequency of | 57 |
in the s | 57 |
the immune response | 57 |
the control group | 55 |
porcine reproductive and | 55 |
in the presence | 55 |
the effect of | 55 |
were used to | 55 |
immune responses to | 55 |
reproductive and respiratory | 55 |
immune response to | 54 |
at the time | 54 |
the incidence of | 53 |
the efficacy of | 53 |
the results of | 53 |
in the control | 53 |
shown to be | 52 |
p and p | 52 |
the majority of | 52 |
at room temperature | 52 |
the importance of | 52 |
the level of | 52 |
of severe acute | 51 |
found to be | 50 |
humoral and cellular | 50 |
to evaluate the | 50 |
and cellular immune | 50 |
the ability of | 50 |
world health organization | 49 |
the production of | 49 |
a variety of | 49 |
the present study | 49 |
the time of | 48 |
immune responses in | 48 |
observed in the | 48 |
a h n | 48 |
the impact of | 48 |
the end of | 47 |
mhc class i | 47 |
high levels of | 47 |
the expression of | 47 |
in terms of | 46 |
on the other | 46 |
respiratory syndrome virus | 46 |
mice immunized with | 46 |
vaccinia virus ankara | 45 |
was observed in | 45 |
as previously described | 45 |
the need for | 45 |
in the absence | 45 |
of h n | 45 |
the spike protein | 45 |
it has been | 44 |
analysis of the | 44 |
safety and efficacy | 44 |
were found to | 44 |
modified vaccinia virus | 43 |
in older adults | 43 |
h n influenza | 43 |
immunogenicity of a | 43 |
the other hand | 43 |
and cd t | 43 |
there is a | 42 |
as a result | 41 |
of neutralizing antibodies | 41 |
that of the | 41 |
human immunodeficiency virus | 41 |
when compared to | 41 |
of the s | 41 |
of the viral | 41 |
has been shown | 40 |
in contrast to | 40 |
as described previously | 40 |
detected in the | 40 |
of influenza virus | 40 |
mvaik rsv g | 40 |
the ability to | 39 |
in response to | 39 |
there is no | 39 |
was used as | 39 |
were challenged with | 39 |
mvaik rsv f | 39 |
end of the | 39 |
and in the | 39 |
mlv mtb wcl | 39 |
of avian infectious | 39 |
some of the | 39 |
cells in the | 39 |
in the present | 39 |
for min at | 38 |
was detected in | 38 |
of the immune | 38 |
for use in | 38 |
the percentage of | 38 |
and efficacy of | 38 |
of the disease | 38 |
neutralizing antibody titers | 38 |
a systematic review | 38 |
used as a | 38 |
such as the | 37 |
ck ch lhlj | 37 |
there was a | 37 |
showed that the | 37 |
ch lhlj v | 37 |
of a vaccine | 37 |
c for min | 36 |
polymerase chain reaction | 36 |
the immune system | 36 |
humoral immune responses | 36 |
of the most | 36 |
the induction of | 36 |
in the vaccine | 36 |
was carried out | 36 |
in our study | 35 |
based on a | 35 |
in the same | 35 |
increase in the | 35 |
t cells in | 35 |
the detection of | 35 |
of a novel | 35 |
feline infectious peritonitis | 35 |
need to be | 35 |
have shown that | 35 |
with mvaik rsv | 35 |
results showed that | 35 |
the authors declare | 34 |
and characterization of | 34 |
of this study | 34 |
of influenza a | 34 |
there was no | 34 |
was determined by | 34 |
the fact that | 34 |
a result of | 34 |
the brighton collaboration | 34 |
in the trachea | 34 |
the generation of | 34 |
the case of | 34 |
the control of | 34 |
in animal models | 33 |
obtained from the | 33 |
part of the | 33 |
in the lungs | 33 |
in this paper | 33 |
the respiratory tract | 33 |
each of the | 33 |
the context of | 33 |
was added to | 33 |
to assess the | 33 |
b and c | 33 |
the immunogenicity of | 33 |
in vitro and | 33 |
of cd t | 33 |
were detected in | 33 |
as part of | 33 |
role in the | 33 |
the n protein | 32 |
used in the | 32 |
shown in table | 32 |
with respect to | 32 |
have been shown | 32 |
for vaccine development | 32 |
in the context | 32 |
protective efficacy of | 32 |
vaccines have been | 32 |
an important role | 32 |
modified vaccinia ankara | 32 |
related to the | 32 |
most of the | 32 |
of west nile | 32 |
this study was | 32 |
at days post | 31 |
all of the | 31 |
the levels of | 31 |
seasonal influenza vaccine | 31 |
of a recombinant | 31 |
samples were collected | 31 |
the lack of | 31 |
in the case | 31 |
used for the | 31 |
control and prevention | 31 |
viral vector vaccines | 31 |
serum samples were | 31 |
the proportion of | 31 |
a dose of | 31 |
were used for | 30 |
a single dose | 30 |
transmissible gastroenteritis virus | 30 |
for disease control | 30 |
be used to | 30 |
of the study | 30 |
at the end | 30 |
can be used | 30 |
associated with the | 30 |
use of the | 30 |
were observed in | 30 |
influenza vaccine in | 30 |
the vaccine was | 30 |
mouth disease virus | 30 |
in balb c | 30 |
well as the | 30 |
it is not | 30 |
in the study | 30 |
important role in | 30 |
weeks of age | 29 |
efficacy of a | 29 |
included in the | 29 |
the prevention of | 29 |
of a new | 29 |
in vero cells | 29 |
authors declare that | 29 |
the surface of | 29 |
as a vaccine | 29 |
as compared to | 29 |
at the same | 29 |
sequence of the | 29 |
an increase in | 29 |
the h n | 29 |
because of the | 29 |
the severe acute | 29 |
are shown in | 29 |
immune response in | 28 |
may not be | 28 |
to participate in | 28 |
ability of the | 28 |
and stored at | 28 |
centers for disease | 28 |
it is possible | 28 |
of the n | 28 |
disease control and | 28 |
acute otitis media | 28 |
associated with a | 28 |
the potential to | 28 |
of the sars | 28 |
to develop a | 28 |
the world health | 28 |
with regard to | 28 |
as described above | 27 |
were obtained from | 27 |
in the field | 27 |
to be a | 27 |
has also been | 27 |
none of the | 27 |
h n pandemic | 27 |
and in vivo | 27 |
a novel coronavirus | 27 |
assessment of the | 27 |
was associated with | 27 |
compared with the | 27 |
found in the | 27 |
has not been | 27 |
was supported by | 27 |
protective immunity in | 27 |
immune responses against | 26 |
were determined by | 26 |
a range of | 26 |
s tr protein | 26 |
that they have | 26 |
caused by the | 26 |
influenza vaccination in | 26 |
the potential for | 26 |
c mice were | 26 |
in recent years | 26 |
seasonal influenza vaccination | 26 |
has been reported | 26 |
similar to the | 26 |
for the development | 26 |
expression of the | 26 |
the vaccine and | 26 |
the effects of | 26 |
it is important | 26 |
in developing countries | 26 |
was found to | 26 |
changes in the | 26 |
influenza a virus | 26 |
t cells were | 26 |
used in this | 26 |
contribute to the | 26 |
around the world | 26 |
declare that they | 26 |
were infected with | 26 |
vitro and in | 26 |
immune responses and | 26 |
in the past | 26 |
with severe acute | 26 |
of influenza vaccination | 26 |
those of the | 25 |
the spread of | 25 |
of the human | 25 |
the cost of | 25 |
during the first | 25 |
the plates were | 25 |
a new caledonia | 25 |
of lc m | 25 |
response to the | 25 |
the safety and | 25 |
the cells were | 25 |
influenza vaccine effectiveness | 25 |
virus infection in | 25 |
in the development | 25 |
was used for | 25 |
of influenza vaccine | 25 |
is associated with | 25 |
it may be | 25 |
characterization of a | 25 |
addition to the | 25 |
likely to be | 25 |
have also been | 25 |
the vaccine is | 25 |
the effectiveness of | 25 |
were collected from | 24 |
the introduction of | 24 |
neutralizing antibodies against | 24 |
reported in this | 24 |
between the two | 24 |
vaccine clinical trial | 24 |
immunodeficiency virus type | 24 |
differences in the | 24 |
evaluation of the | 24 |
the safety of | 24 |
be used as | 24 |
the s gene | 24 |
consistent with the | 24 |
have been reported | 24 |
specific cd t | 24 |
the current study | 24 |
it can be | 24 |
the burden of | 24 |
with or without | 24 |
can be found | 24 |
derived from the | 24 |
we found that | 24 |
the possibility of | 24 |
protective immunity against | 24 |
were used as | 24 |
to influence the | 24 |
needs to be | 24 |
more than one | 24 |
t cell response | 24 |
and incubated at | 24 |
prevention and control | 24 |
they have no | 24 |
than that of | 23 |
to identify the | 23 |
and public health | 23 |
of seasonal influenza | 23 |
nci h cells | 23 |
significantly higher than | 23 |
the arkga p | 23 |
approved by the | 23 |
participate in a | 23 |
was performed using | 23 |
the results showed | 23 |
the most common | 23 |
immunized with mvaik | 23 |
evaluation of a | 23 |
valley fever virus | 23 |
results of the | 23 |
coronavirus spike protein | 23 |
could not be | 23 |
in the first | 23 |
rsv g or | 23 |
in mice and | 23 |
added to the | 23 |
supported by the | 23 |
influenza and rsv | 23 |
for a vaccine | 23 |
no known competing | 23 |
in the netherlands | 23 |
for the prevention | 23 |
were added to | 23 |
on the surface | 23 |
use of a | 23 |
provided by the | 23 |
development of vaccines | 23 |
inactivated sars vaccine | 23 |
vaccine in the | 23 |
have no known | 23 |
each group were | 22 |
immunogenicity of the | 22 |
c for h | 22 |
the evaluation of | 22 |
of s tr | 22 |
recombinant vesicular stomatitis | 22 |
financial interests or | 22 |
in the future | 22 |
which may be | 22 |
a significant increase | 22 |
are associated with | 22 |
the favn assay | 22 |
development of the | 22 |
adjuvanted h n | 22 |
the work reported | 22 |
interests or personal | 22 |
memory t cells | 22 |
canine visceral leishmaniasis | 22 |
of public health | 22 |
human and animal | 22 |
appeared to influence | 22 |
humoral immune response | 22 |
that could have | 22 |
to accept a | 22 |
summarized in table | 22 |
competing financial interests | 22 |
for the detection | 22 |
there were no | 22 |
of influenza b | 22 |
or personal relationships | 22 |
any of the | 22 |
the last years | 22 |
of the spike | 22 |
of the recombinant | 22 |
relationships that could | 22 |
involved in the | 22 |
known competing financial | 22 |
of the total | 22 |
were inoculated with | 22 |
in hong kong | 22 |
have appeared to | 22 |
in embryonated eggs | 22 |
levels of neutralizing | 22 |
could have appeared | 22 |
personal relationships that | 22 |
red blood cells | 22 |
were collected at | 22 |
weeks after the | 22 |
depending on the | 22 |
is important to | 22 |
the identification of | 22 |
considered to be | 22 |
in combination with | 21 |
reduction in the | 21 |
suggest that the | 21 |
vaccine has been | 21 |
is the most | 21 |
a dna vaccine | 21 |
of the influenza | 21 |
c and d | 21 |
region of the | 21 |
influence the work | 21 |
g or f | 21 |
that can be | 21 |
were collected and | 21 |
in cotton rats | 21 |
work reported in | 21 |
to get vaccinated | 21 |
is an important | 21 |
characterization of the | 21 |
to reduce the | 21 |
it is likely | 21 |
were immunized with | 21 |
incubated for h | 21 |
to investigate the | 21 |
number of cases | 21 |
to be used | 21 |
significant increase in | 21 |
the amount of | 21 |
protein of the | 21 |
indicated that the | 21 |
have been developed | 21 |
the availability of | 21 |
as an adjuvant | 21 |
viral load in | 21 |
the most important | 21 |
factors associated with | 21 |
syndrome coronavirus spike | 20 |
in the current | 20 |
members of the | 20 |
be due to | 20 |
coronavirus infectious bronchitis | 20 |
cytotoxic t lymphocytes | 20 |
research and development | 20 |
present in the | 20 |
protective immune response | 20 |
would like to | 20 |
g for min | 20 |
demonstrated that the | 20 |
a live attenuated | 20 |
h n virus | 20 |
the placebo group | 20 |
of the antibody | 20 |
from each group | 20 |
herpes simplex virus | 20 |
cases and controls | 20 |
for the presence | 20 |
in the last | 20 |
newcastle disease virus | 20 |
in each group | 20 |
of middle east | 20 |
of specific igy | 20 |
sera were collected | 20 |
h n and | 20 |
is needed to | 20 |
s dna vaccine | 20 |
and safety of | 20 |
of influenza vaccines | 20 |
more than of | 20 |
future h n | 20 |
results indicated that | 20 |
simian immunodeficiency virus | 20 |
of age and | 20 |
has been used | 20 |
higher than the | 20 |
a reduction in | 20 |
have not been | 20 |
in which the | 20 |
spike protein of | 20 |
for detection of | 20 |
the neutralizing antibody | 20 |
of neutralizing antibody | 20 |
to be the | 20 |
a phase i | 20 |
identification of a | 20 |
for the first | 20 |
the emergence of | 20 |
colostrum and milk | 20 |
at least one | 20 |
virus in the | 20 |
and days post | 20 |
have been used | 20 |
of a live | 20 |
of the same | 20 |
mice were vaccinated | 19 |
specific immune responses | 19 |
in patients with | 19 |
is based on | 19 |
influenza virus infection | 19 |
old or older | 19 |
wide range of | 19 |
in herd b | 19 |
influenza a h | 19 |
years old or | 19 |
is responsible for | 19 |
to that of | 19 |
against challenge with | 19 |
days after vaccination | 19 |
a decrease in | 19 |
t cells and | 19 |
like to thank | 19 |
is likely to | 19 |
of the world | 19 |
of the genome | 19 |
during the study | 19 |
a role in | 19 |
the increase in | 19 |
trachea and kidney | 19 |
were incubated at | 19 |
national institutes of | 19 |
responsible for the | 19 |
it will be | 19 |
the study period | 19 |
ministry of health | 19 |
due to a | 19 |
in comparison to | 19 |
neutralizing antibodies in | 19 |
the activation of | 19 |
cells were washed | 19 |
nile virus infection | 19 |
the duration of | 19 |
years age group | 19 |
le poly iclc | 19 |
accept a future | 19 |
for development of | 19 |
the concentration of | 19 |
to the vaccine | 19 |
the poultry industry | 19 |
in cell culture | 19 |
department of health | 19 |
months of age | 19 |
correlates of protection | 19 |
comparison of the | 19 |
protective immune responses | 19 |
resulted in a | 19 |
be associated with | 18 |
as described in | 18 |
rna was extracted | 18 |
in both the | 18 |
a series of | 18 |
willingness to accept | 18 |
mice were immunized | 18 |
rabbit haemorrhagic disease | 18 |
of the two | 18 |
the antibody response | 18 |
the ad vector | 18 |
the vector is | 18 |
the innate immune | 18 |
of the rh | 18 |
analysis was performed | 18 |
higher in the | 18 |
of at least | 18 |
in mammalian cells | 18 |
of infectious diseases | 18 |
single dose of | 18 |
efficacy of the | 18 |
the value of | 18 |
and evaluation of | 18 |
safe and effective | 18 |
disease in the | 18 |
antibodies to the | 18 |
and it is | 18 |
the university of | 18 |
ml of the | 18 |
cells infected with | 18 |
in the population | 18 |
have to be | 18 |
fetal bovine serum | 18 |
of the population | 18 |
this article can | 18 |
recombinant vaccinia virus | 18 |
of mice with | 18 |
a public health | 18 |
in the elderly | 18 |
in a single | 18 |
amino acid changes | 18 |
a future h | 18 |
understanding of the | 18 |
a and nci | 18 |
the purpose of | 18 |
days of age | 18 |
animals and humans | 18 |
be used in | 18 |
this work was | 18 |
and nci h | 18 |
of the vaccinated | 18 |
article can be | 18 |
levels in the | 18 |
igg and igg | 18 |
embryonated chicken eggs | 18 |
be used for | 18 |
and mortality in | 18 |
venezuelan equine encephalitis | 18 |
it is a | 18 |
and incubated for | 18 |
is consistent with | 18 |
institutes of health | 18 |
modified live virus | 18 |
cov s dna | 18 |
were incubated with | 18 |
vaccinated with the | 18 |
that have been | 18 |
emerging infectious diseases | 18 |
rats immunized with | 18 |
pandemic influenza a | 18 |
plates were incubated | 18 |
pandemic influenza vaccine | 18 |
the influence of | 18 |
were carried out | 18 |
systematic review and | 18 |
fc fusion protein | 18 |
viral respiratory infections | 18 |
prior to the | 18 |
of the vector | 18 |
a vaccine against | 18 |
were vaccinated with | 18 |
vaccines based on | 18 |
of canine parvovirus | 18 |
vaccine development and | 17 |
veterinary and human | 17 |
were able to | 17 |
in the vaccinated | 17 |
of immune response | 17 |
the first time | 17 |
adaptive immune responses | 17 |
which have been | 17 |
japanese encephalitis virus | 17 |
indicating that the | 17 |
days after the | 17 |
were incubated for | 17 |
the recombinant virus | 17 |
added to each | 17 |
been used to | 17 |
to be effective | 17 |
review of the | 17 |
ep and cp | 17 |
play an important | 17 |
the magnitude of | 17 |
appear to be | 17 |
adjuvanted influenza a | 17 |
a new vaccine | 17 |
the public health | 17 |
referred to as | 17 |
dependent enhancement of | 17 |
effects of the | 17 |
the basis of | 17 |
of dengue virus | 17 |
the potential of | 17 |
of the national | 17 |
to determine whether | 17 |
and animal health | 17 |
hepatitis b vaccine | 17 |
report of the | 17 |
that could be | 17 |
of a single | 17 |
the same time | 17 |
memory t cell | 17 |
rsv subgroup a | 17 |
respiratory disease in | 17 |
infected with the | 17 |
s tr expression | 17 |
was obtained from | 17 |
were included in | 17 |
vaccine based on | 17 |
republic of china | 17 |
that in the | 17 |
antibodies against rsv | 17 |
influenza b virus | 17 |
could be used | 17 |
clinical signs and | 17 |
antibody titers were | 17 |
by flow cytometry | 17 |
female balb c | 17 |
should not be | 17 |
induced by the | 17 |
in saudi arabia | 17 |
there has been | 17 |
in accordance with | 17 |
a lack of | 17 |
a wide range | 17 |
have been identified | 17 |
a review of | 17 |
cells were infected | 17 |
upper respiratory tract | 17 |
is not a | 17 |
cotton rats immunized | 17 |
identification of the | 17 |
more likely to | 17 |
of t cell | 17 |
ibv ck ch | 17 |
the wild type | 16 |
innate immune response | 16 |
to each well | 16 |
equal volume of | 16 |
between p and | 16 |
of t cells | 16 |
otitis media in | 16 |
the type of | 16 |
is expected to | 16 |
with the exception | 16 |
challenge with the | 16 |
to enhance the | 16 |
to ensure that | 16 |
in the respiratory | 16 |
viral rna replication | 16 |
structure of the | 16 |
is possible that | 16 |
antibody titers in | 16 |
many of the | 16 |
levels of the | 16 |
their ability to | 16 |
antibody responses to | 16 |
the severity of | 16 |
one or more | 16 |
regulatory t cells | 16 |
in the day | 16 |
to improve the | 16 |
is likely that | 16 |
cov s protein | 16 |
a positive control | 16 |
porcine epidemic diarrhea | 16 |
peripheral blood mononuclear | 16 |
vaccinated with prrs | 16 |
blood mononuclear cells | 16 |
effectiveness of the | 16 |
of porcine reproductive | 16 |
a concentration of | 16 |
to understand the | 16 |
public health and | 16 |
an animal model | 16 |
of the antigen | 16 |
and identification of | 16 |
immunity in mice | 16 |
neutralizing antibody response | 16 |
wild type virus | 16 |
live virus vaccine | 16 |
serve as a | 16 |
antibodies against the | 16 |
of modified vaccinia | 16 |
the application of | 16 |
were found in | 16 |
carried out using | 16 |
cellular and humoral | 16 |
infectious peritonitis virus | 16 |
could also be | 16 |
the rn protein | 16 |
regard to the | 16 |
to meet the | 16 |
antibody levels in | 16 |
that the vaccine | 16 |
neutralizing antibodies were | 16 |
half of the | 16 |
in the americas | 16 |
it would be | 16 |
time pcr assays | 16 |
mucosal and systemic | 16 |
arkga p vaccine | 16 |
activation of the | 16 |
antibody response to | 16 |
with the same | 16 |
as a positive | 16 |
on day after | 16 |
groups of mice | 16 |
in a vaccine | 16 |
lower than the | 16 |
study of the | 16 |
a member of | 15 |
one dose of | 15 |
cov spike protein | 15 |
inactivated influenza vaccine | 15 |
similar to those | 15 |
antigen presenting cells | 15 |
to be vaccinated | 15 |
the day and | 15 |
vaccine adverse events | 15 |
lymph node cells | 15 |
poly iclc and | 15 |
work was supported | 15 |
and development of | 15 |
are needed to | 15 |
in more than | 15 |
pigs vaccinated with | 15 |
avian coronavirus infectious | 15 |
the virus was | 15 |
in vaccine development | 15 |
are summarized in | 15 |
cells were then | 15 |
after the last | 15 |
of balb c | 15 |
has to be | 15 |
the viral vector | 15 |
of influenza viruses | 15 |
of vaccine adverse | 15 |
it should be | 15 |
parainfluenza virus type | 15 |
has been demonstrated | 15 |
lactis gem particles | 15 |
efficacy and safety | 15 |
and can be | 15 |
the yellow fever | 15 |
of new vaccines | 15 |
advisory committee on | 15 |
compared with those | 15 |
antibodies in the | 15 |
in the serum | 15 |
lead to the | 15 |
the exception of | 15 |
are likely to | 15 |
review and meta | 15 |
data suggest that | 15 |
was defined as | 15 |
of vaccinia virus | 15 |
the need to | 15 |
the pathogenesis of | 15 |
respiratory tract infections | 15 |
vaccination coverage among | 15 |
associated with influenza | 15 |
at and days | 15 |
of sars coronavirus | 15 |
expression of a | 15 |
higher than that | 15 |
health care workers | 15 |
cellular immune response | 15 |
the day group | 15 |
which is a | 15 |
of the target | 15 |
of health and | 15 |
in of the | 15 |
of the respiratory | 15 |
the us and | 15 |
group that received | 15 |
majority of the | 15 |
been found to | 15 |
m and n | 15 |
igg and iga | 15 |
with that of | 15 |
with a recombinant | 15 |
and distribution of | 15 |
and incubated with | 15 |
was able to | 15 |
two doses of | 15 |
a future covid | 15 |
responses in mice | 15 |
with ml of | 15 |
was extracted from | 15 |
no significant differences | 15 |
type i ifn | 15 |
the m protein | 15 |
this is the | 15 |
used as the | 15 |
in a mouse | 15 |
serial passages in | 15 |
vaccine candidates in | 15 |
that had been | 15 |
were used in | 15 |
m and s | 15 |
similar to that | 15 |
and days after | 15 |
effect of the | 15 |
the extent of | 15 |
to be more | 15 |
conflict of interest | 15 |
room temperature for | 15 |
regions of the | 15 |
the vaccine group | 15 |
neutralizing antibodies and | 15 |
is able to | 15 |
rsv g and | 15 |
result of the | 15 |
may also be | 15 |
expressed as the | 15 |
as a control | 15 |
presence of the | 15 |
indicates that the | 15 |
magnitude of the | 15 |
differences between the | 15 |
the sars coronavirus | 15 |
adolescents and adults | 15 |
a modified live | 15 |
flow cytometric analysis | 14 |
with a single | 14 |
patient information leaflet | 14 |
human and veterinary | 14 |
of immune responses | 14 |
in clinical trials | 14 |
gene of the | 14 |
were maintained in | 14 |
a negative control | 14 |
to the high | 14 |
in the uk | 14 |
responses induced by | 14 |
be able to | 14 |
the formation of | 14 |
were analyzed by | 14 |
the past years | 14 |
of respiratory syncytial | 14 |
vaccination in the | 14 |
the age of | 14 |
the virus and | 14 |
appears to be | 14 |
cell responses in | 14 |
vaccines for the | 14 |
for min and | 14 |
indicate that the | 14 |
acceptability of a | 14 |
the wnv e | 14 |
increased frequency of | 14 |
in infants and | 14 |
week after the | 14 |
for human use | 14 |
in the u | 14 |
also observed in | 14 |
vaccination with a | 14 |
and use of | 14 |
results in the | 14 |
diagnosis of pertussis | 14 |
animals vaccinated with | 14 |
the addition of | 14 |
after vaccination with | 14 |
vaccine in a | 14 |
administration of a | 14 |
the united kingdom | 14 |
the aim of | 14 |
determined by the | 14 |
response to a | 14 |
the negative control | 14 |
with pfu of | 14 |
vaccine safety and | 14 |
the group that | 14 |
risk factors for | 14 |
led to the | 14 |
the loss of | 14 |
were positive for | 14 |
seen in the | 14 |
virus capsid protein | 14 |
an equal volume | 14 |
day of age | 14 |
live attenuated vaccines | 14 |
avian influenza a | 14 |
blood samples were | 14 |
of the p | 14 |
the s and | 14 |
in the frequency | 14 |
the most advanced | 14 |
the viral rna | 14 |
from the same | 14 |
and s proteins | 14 |
of influenza and | 14 |
clinical signs were | 14 |
carried out in | 14 |
coronavirus associated with | 14 |
studies have shown | 14 |
animal models and | 14 |
health center patients | 14 |
the administration of | 14 |
virus and the | 14 |
results indicate that | 14 |
associated with this | 14 |
the pseudotype assay | 14 |
the treatment of | 14 |
can also be | 14 |
epidemic diarrhea virus | 14 |
reported in the | 14 |
the secretion of | 14 |
over the past | 14 |
member of the | 14 |
neutralizing antibody titer | 14 |
funded health centers | 14 |
in the early | 14 |
the preparation of | 14 |
immune responses of | 14 |
the construction of | 14 |
food and drug | 14 |
making and implementation | 14 |
of vaccines to | 14 |
contrast to the | 14 |
of vaccines and | 14 |
followed by a | 14 |
infectious bronchitis coronavirus | 14 |
in line with | 14 |
the characteristics of | 14 |
influenza vaccination coverage | 14 |
of the e | 14 |
is one of | 14 |
were performed in | 14 |
it is also | 14 |
position of the | 14 |
significantly lower than | 14 |
have the potential | 14 |
health and human | 14 |
and protective efficacy | 14 |
a mouse model | 14 |
may be a | 14 |
the viral load | 14 |
at a dose | 14 |
of a future | 14 |
vaccine candidates are | 14 |
the response to | 14 |
the s subunit | 14 |
of the placebo | 14 |
on day of | 14 |
the occurrence of | 14 |
cats of the | 14 |
cervical lymph node | 13 |
the influenza vaccine | 13 |
human mhc class | 13 |
the centers for | 13 |
the nucleocapsid protein | 13 |
of the severe | 13 |
were subjected to | 13 |
high titers of | 13 |
reaction was stopped | 13 |
used as an | 13 |
deletion of the | 13 |
in the usa | 13 |
as described by | 13 |
the virus is | 13 |
spread of the | 13 |
lethal challenge with | 13 |
at a concentration | 13 |
nature of the | 13 |
were significantly higher | 13 |
tr protein expression | 13 |
determined to be | 13 |
a clinical trial | 13 |
conjugated goat anti | 13 |
in agreement with | 13 |
lower than that | 13 |
global public health | 13 |
in vaccinated and | 13 |
infants and children | 13 |
systemic and mucosal | 13 |
of an inactivated | 13 |
were tested for | 13 |
to be safe | 13 |
may contribute to | 13 |
the result of | 13 |
for this study | 13 |
funded by the | 13 |
may be the | 13 |
of the covid | 13 |
of these vaccines | 13 |
of infection in | 13 |
mice vaccinated with | 13 |
plates were washed | 13 |
were examined for | 13 |
of transmissible gastroenteritis | 13 |
on days and | 13 |
the day of | 13 |
suggests that the | 13 |
did not induce | 13 |
the lungs of | 13 |
study was to | 13 |
and pandemic influenza | 13 |
as for the | 13 |
the course of | 13 |
comparable to that | 13 |
and stained with | 13 |
to pay for | 13 |
the recombinant protein | 13 |
the vaccine strain | 13 |
the early s | 13 |
high level of | 13 |
s and n | 13 |
was detected at | 13 |
at the n | 13 |
t h response | 13 |
can serve as | 13 |
of vaccines in | 13 |
in healthy adults | 13 |
may lead to | 13 |
in humans and | 13 |
of pandemic influenza | 13 |
that there are | 13 |
the modified live | 13 |
and respiratory syncytial | 13 |
a vaccine for | 13 |
associated with severe | 13 |
as a means | 13 |
in the following | 13 |
the mice were | 13 |
calves in herd | 13 |
viral rna was | 13 |
were divided into | 13 |
the most effective | 13 |
dose of the | 13 |
purified inactivated sars | 13 |
of vaccine safety | 13 |
due to its | 13 |
vector and vaccine | 13 |
to those of | 13 |
the disease burden | 13 |
is the first | 13 |
confirmed influenza pneumonia | 13 |
mucosal immune system | 13 |
this study is | 13 |
were included as | 13 |
passive transfer of | 13 |
in a number | 13 |
day after the | 13 |
the acceptability of | 13 |
did not show | 13 |
incubated for min | 13 |
syndrome coronavirus infection | 13 |
presence of a | 13 |
a means of | 13 |
is required for | 13 |
and human health | 13 |
could be detected | 13 |
in this experiment | 13 |
to examine the | 13 |
lower respiratory tract | 13 |
resulted in the | 13 |
and of the | 13 |
g ml of | 13 |
all rights reserved | 13 |
role of the | 13 |
to the development | 13 |
out of the | 13 |
the west nile | 13 |
it was not | 13 |
is capable of | 13 |
and have been | 13 |
in young children | 13 |
vaccines and vaccination | 13 |
in public health | 13 |
mice that received | 13 |
for h and | 13 |
there are several | 13 |
and duration of | 13 |
t cells are | 13 |
but not in | 13 |
in this regard | 13 |
to be considered | 13 |
the spike gene | 13 |
care and use | 13 |
to compare the | 13 |
was used in | 13 |
were performed using | 13 |
the process of | 13 |
innate and adaptive | 13 |
for protection against | 12 |
the in vivo | 12 |
of human immunodeficiency | 12 |
be attributed to | 12 |
characteristics of the | 12 |
detection of the | 12 |
are expected to | 12 |
and human services | 12 |
the beginning of | 12 |
animal care and | 12 |
intranasal administration of | 12 |
the v swg | 12 |
this suggests that | 12 |
after the third | 12 |
to create a | 12 |
t cell epitopes | 12 |
caused by a | 12 |
proved to be | 12 |
were compared with | 12 |
using the same | 12 |
were measured by | 12 |
protein expression in | 12 |
serial dilutions of | 12 |
pathogenic avian influenza | 12 |
need for a | 12 |
did not have | 12 |
response to vaccination | 12 |
the attenuation of | 12 |
animal and human | 12 |
results of this | 12 |
the stimulation of | 12 |
the establishment of | 12 |
molecular weight of | 12 |
was assessed by | 12 |
attenuated vaccinia virus | 12 |
a single immunization | 12 |
of cases of | 12 |
clinical trials in | 12 |
cells were incubated | 12 |
the ive against | 12 |
to protect against | 12 |
stability of the | 12 |
and humoral immune | 12 |
the results are | 12 |
h n vaccines | 12 |
there is an | 12 |
neutralizing antibody responses | 12 |
been observed in | 12 |
belonging to the | 12 |
to induce a | 12 |
and control of | 12 |
subgroups a and | 12 |
in the host | 12 |
incidence of diarrhoea | 12 |
to be an | 12 |
of antibodies to | 12 |
received the vaccine | 12 |
only a few | 12 |
the cause of | 12 |
vero e cells | 12 |
s and s | 12 |
of the cell | 12 |
specific immune response | 12 |
the e gene | 12 |
capable of inducing | 12 |
influenza h n | 12 |
before and after | 12 |
impact on the | 12 |
for the vaccine | 12 |
the existence of | 12 |
the study was | 12 |
and mvaik rsv | 12 |
low levels of | 12 |
the site of | 12 |
of cd and | 12 |
recommendations of the | 12 |
antibody responses in | 12 |
mice were sacrificed | 12 |
antibody response in | 12 |
the health center | 12 |
will be the | 12 |
cervical lymph nodes | 12 |
were coated with | 12 |
influenza vaccine uptake | 12 |
were analyzed using | 12 |
responses against sars | 12 |
each sample was | 12 |
administration of the | 12 |
avian influenza viruses | 12 |
total number of | 12 |
in pigs vaccinated | 12 |
open reading frame | 12 |
of a covid | 12 |
dose of pfu | 12 |
vaccine efficacy and | 12 |
is caused by | 12 |
infectious bronchitis viruses | 12 |
number of studies | 12 |
which is the | 12 |
are required for | 12 |
bronchitis virus in | 12 |
in relation to | 12 |
this is a | 12 |
this indicates that | 12 |
was performed to | 12 |
infected with a | 12 |
the persistence of | 12 |
in mice immunized | 12 |
are known to | 12 |
and h n | 12 |
at this time | 12 |
as a negative | 12 |
to increase the | 12 |
yellow fever vaccine | 12 |
canine parvovirus type | 12 |
and drug administration | 12 |
plays an important | 12 |
in the human | 12 |
of a modified | 12 |
been associated with | 12 |
full s mf | 12 |
heard of h | 12 |
of nucleic acid | 12 |
with a high | 12 |
of otitis media | 12 |
the opportunity to | 12 |
difference between the | 12 |
intranasal delivery of | 12 |
vero cells were | 12 |
introduction of the | 12 |
rotavirus and coronavirus | 12 |
vaccinated against covid | 12 |
the growth of | 12 |
of ebola virus | 12 |
results from the | 12 |
of rabies in | 12 |
that it is | 12 |
countries in the | 12 |
of the global | 12 |
in cho dhfr | 12 |
sequencing of the | 12 |
group of experts | 12 |
was shown to | 12 |
of feline infectious | 12 |
memory cd t | 12 |
against west nile | 12 |
against myxomatosis and | 12 |
for at least | 12 |
in this report | 12 |
after the first | 12 |
yellow fever virus | 12 |
there was an | 12 |
to determine if | 12 |
for control of | 12 |
on day post | 12 |
specific cytotoxic t | 12 |
use as a | 12 |
be noted that | 12 |
results show that | 12 |
disease burden of | 12 |
will need to | 12 |
and young children | 12 |
risk assessment of | 12 |
secretion of il | 12 |
genetic stability of | 12 |
and adaptive immune | 12 |
coronavirus spike glycoprotein | 12 |
that they are | 12 |
this age group | 12 |
the middle east | 12 |
protective effect of | 12 |
is possible to | 12 |
for influenza a | 12 |
views on the | 12 |
not statistically significant | 12 |
the distribution of | 12 |
based on these | 12 |
developed by the | 12 |
burden of influenza | 12 |
with an equal | 12 |
for a covid | 12 |
in the generation | 12 |
the results indicated | 12 |
for older adults | 12 |
for respiratory disease | 12 |
of virus in | 12 |
key considerations for | 12 |
oral administration of | 12 |
min at room | 12 |
working group on | 12 |
by the vaccine | 12 |
central nervous system | 12 |
influenza and other | 12 |
the prevalence of | 12 |
proven to be | 12 |
together with the | 12 |
a viral vector | 12 |
influenza a viruses | 12 |
the cd t | 12 |
responses to vaccines | 12 |
and protection against | 12 |
in the world | 12 |
hong kong and | 12 |
c bl mice | 11 |
determined by elisa | 11 |
can be seen | 11 |
in rhesus monkeys | 11 |
were housed in | 11 |
of avian influenza | 11 |
immune response against | 11 |
to take siv | 11 |
on the acceptability | 11 |
was performed in | 11 |
influenza viruses in | 11 |
the mhc class | 11 |
increased risk of | 11 |
to prevent the | 11 |
properties of the | 11 |
with rsv subgroup | 11 |
appeared to be | 11 |
vaccine may be | 11 |
to produce a | 11 |
with a dose | 11 |
the period of | 11 |
hek t cells | 11 |
cell responses to | 11 |
in this case | 11 |
and the results | 11 |
data were analyzed | 11 |
mortality in the | 11 |
the onset of | 11 |
was significantly higher | 11 |
and igg a | 11 |
both humoral and | 11 |
against h n | 11 |
in the viral | 11 |
of the second | 11 |
at years post | 11 |
for public health | 11 |
by the national | 11 |
the working group | 11 |
of enhanced disease | 11 |
was lower than | 11 |
of nk cells | 11 |
a history of | 11 |
able to induce | 11 |
titers of the | 11 |
dilution of the | 11 |
data indicate that | 11 |
the relative importance | 11 |
means of preventing | 11 |
against lethal challenge | 11 |
immune response and | 11 |
dna vaccine induces | 11 |
can lead to | 11 |
determination of the | 11 |
immunogenicity and protective | 11 |
for this purpose | 11 |
committee on immunization | 11 |
studies have been | 11 |
its ability to | 11 |
was not observed | 11 |
the cervical lymph | 11 |
safety working group | 11 |
serial passage in | 11 |
the samples were | 11 |
in the sera | 11 |
an example of | 11 |
compared to those | 11 |
was measured by | 11 |
to obtain a | 11 |
expression of cd | 11 |
this type of | 11 |
use of vaccines | 11 |
in comparison with | 11 |
chickens inoculated with | 11 |
can be achieved | 11 |
protein is a | 11 |
and its derivatives | 11 |
of the three | 11 |
were cultured in | 11 |
classical swine fever | 11 |
of the individual | 11 |
the supernatant was | 11 |
of disease enhancement | 11 |
have been found | 11 |
the form of | 11 |
of dendritic cells | 11 |
mouse hepatitis virus | 11 |
contributed to the | 11 |
the influenza virus | 11 |
time of first | 11 |
development of new | 11 |
respiratory infections in | 11 |
efforts to develop | 11 |
the vector and | 11 |
the challenge of | 11 |
total rna was | 11 |
to test the | 11 |
many of these | 11 |
borne encephalitis virus | 11 |
that there was | 11 |
then challenged with | 11 |
single immunization with | 11 |
the basis for | 11 |
a determinant of | 11 |
suggested that the | 11 |
days prior to | 11 |
attenuated influenza vaccine | 11 |
highly pathogenic avian | 11 |
is a major | 11 |
was performed on | 11 |
is difficult to | 11 |
of rabies virus | 11 |
is that the | 11 |
groups of balb | 11 |
vaccine candidate for | 11 |
immunogenicity and safety | 11 |
were shown to | 11 |
other respiratory viruses | 11 |
influenza a and | 11 |
was collected and | 11 |
probability of vaccine | 11 |
reciprocal of the | 11 |
willingness to pay | 11 |
the ratio of | 11 |
we would like | 11 |
focused on the | 11 |
by the s | 11 |
spike protein is | 11 |
of a sars | 11 |
immunity in the | 11 |
analyses were performed | 11 |
were associated with | 11 |
of vaccine development | 11 |
is also a | 11 |
participate in the | 11 |
the disease is | 11 |
n influenza virus | 11 |
have demonstrated that | 11 |
development of an | 11 |
natural killer cells | 11 |
between cases and | 11 |
the amino acid | 11 |
as evidenced by | 11 |
on the basis | 11 |
to estimate the | 11 |
immunized with the | 11 |
of cell culture | 11 |
vaccinated and control | 11 |
the general population | 11 |
the development and | 11 |
version of the | 11 |
in the production | 11 |
of the birds | 11 |
in children with | 11 |
to a lesser | 11 |
mice were challenged | 11 |
blood was collected | 11 |
the analysis of | 11 |
eggs were inoculated | 11 |
of first vaccination | 11 |
infection in the | 11 |
reduction in viral | 11 |
global vaccine action | 11 |
the vaccine in | 11 |
which has been | 11 |
challenged with sars | 11 |
of the innate | 11 |
amino acid sequence | 11 |
influenza vaccines in | 11 |
west nile vaccine | 11 |
of the different | 11 |
oral polio vaccine | 11 |
in the second | 11 |
to be highly | 11 |
of the current | 11 |
also be used | 11 |
and has been | 11 |
of the original | 11 |
n influenza vaccine | 11 |
been reported that | 11 |
respect to the | 11 |
in the group | 11 |
results of a | 11 |
wnv e glycoprotein | 11 |
of the inactivated | 11 |
frequency of ifn | 11 |
a pool of | 11 |
efficacy of an | 11 |
it is difficult | 11 |
at day and | 11 |
previous studies have | 11 |
cells of the | 11 |
of the challenge | 11 |
what is the | 11 |
of the last | 11 |
iclc and le | 11 |
amino acid substitutions | 11 |
cells were used | 11 |
the disease in | 11 |
specific for the | 11 |
adaptive immune response | 11 |
and the virus | 11 |
safety of the | 11 |
and le poly | 11 |
to ensure the | 11 |
the inactivation process | 11 |
immunogenicity of an | 11 |
one week after | 11 |
in a covid | 11 |
doses of the | 11 |
to confirm the | 11 |
s yz strains | 11 |
shown to induce | 11 |
than in the | 11 |
specific neutralizing antibodies | 11 |
a protective immune | 11 |
patients with severe | 11 |
the protective efficacy | 11 |
the design of | 11 |
production of a | 11 |
innate immune system | 11 |
was tested in | 11 |
a study of | 11 |
of vaccines against | 11 |
of acute otitis | 11 |
hepatitis c virus | 11 |
for use as | 11 |
followed by the | 11 |
vaccine action plan | 11 |
the reciprocal of | 11 |
responses to the | 11 |
that there is | 11 |
ndv or ampv | 11 |
influenza vaccine and | 11 |
vaccine and placebo | 11 |
estimated to be | 11 |
public health emergency | 11 |
were based on | 11 |
was added and | 11 |
for prevention of | 11 |
was analyzed by | 11 |
of viral replication | 11 |
response against the | 11 |
and that the | 11 |
for epidemic preparedness | 11 |
is replication incompetent | 10 |
was calculated by | 10 |
vaccine for the | 10 |
african green monkeys | 10 |
vaccine and the | 10 |
titer of the | 10 |
were expressed as | 10 |
demonstrate that the | 10 |
disease prevention and | 10 |
component of the | 10 |
a recent study | 10 |
for this reason | 10 |
recombinant swinepox virus | 10 |
with the potential | 10 |
of human and | 10 |
viral replication in | 10 |
the membrane was | 10 |
more prone to | 10 |
transmission of the | 10 |
vaccination arrangement procedure | 10 |
the inactivation of | 10 |
the determination of | 10 |
of the beaur | 10 |
with elevated activity | 10 |
the causative agent | 10 |
in the spike | 10 |
was not detected | 10 |
of all the | 10 |
should be noted | 10 |
respiratory tract of | 10 |
have been the | 10 |
in the online | 10 |
and function of | 10 |
world health organisation | 10 |
cell epitopes in | 10 |
of this approach | 10 |
live attenuated vaccine | 10 |
number of children | 10 |
been reported to | 10 |
they are not | 10 |
has the potential | 10 |
year of life | 10 |
and m proteins | 10 |
in light of | 10 |
the highest dilution | 10 |
after challenge with | 10 |
positive for influenza | 10 |
spf chicken eggs | 10 |
infection and disease | 10 |
parts of the | 10 |
during the influenza | 10 |
into three groups | 10 |
no difference in | 10 |
an effective vaccine | 10 |
has recently been | 10 |
the trachea and | 10 |
the release of | 10 |
ampv subtype b | 10 |
of b cells | 10 |
of the viruses | 10 |
found that the | 10 |
for each group | 10 |
virus as a | 10 |
of mtb wcl | 10 |
only in the | 10 |
linked immunosorbent assay | 10 |
syncytial virus infection | 10 |
the vaccinated mice | 10 |
by the manufacturer | 10 |
source of infection | 10 |
the diagnosis of | 10 |
different time points | 10 |
coronavirus nucleocapsid protein | 10 |
children in the | 10 |
the objective of | 10 |
the significance of | 10 |
the source of | 10 |
is required to | 10 |
such as influenza | 10 |
binding domain of | 10 |
will not be | 10 |
vector vaccines safety | 10 |
to influenza virus | 10 |
novel coronavirus associated | 10 |
in mdck pf | 10 |
the t cell | 10 |
mhc class ii | 10 |
protection against lethal | 10 |
producing cd t | 10 |
were observed for | 10 |
a group of | 10 |
for vaccine production | 10 |
and nk cells | 10 |
was observed after | 10 |
the vaccine to | 10 |
the titers of | 10 |
institutional animal care | 10 |
diarrhoea and mortality | 10 |
the selection of | 10 |
according to their | 10 |
shown in the | 10 |
chickens infected with | 10 |
significant reduction in | 10 |
induce protective immunity | 10 |
rsv subgroups a | 10 |
relative importance of | 10 |
in insect cells | 10 |
the disease and | 10 |
thought to be | 10 |
information and patient | 10 |
and there is | 10 |
was due to | 10 |
resulting in a | 10 |
the mucosal immune | 10 |
be involved in | 10 |
was performed with | 10 |
vaccination of hcws | 10 |
hepatitis b virus | 10 |
in the as | 10 |
to the virus | 10 |
as a vector | 10 |
in some countries | 10 |
the global vaccine | 10 |
and new zealand | 10 |
influenza virus in | 10 |
induced by a | 10 |
three times with | 10 |
sequence analysis of | 10 |
after the challenge | 10 |
we investigated the | 10 |
a significantly higher | 10 |
of the first | 10 |
the association of | 10 |
in mammary secretions | 10 |
protection against virulent | 10 |
infants and young | 10 |
into account the | 10 |
the specificity of | 10 |
the national institutes | 10 |
the plate was | 10 |
b nasal spray | 10 |
of infectious virus | 10 |
course of the | 10 |
mdck pf cells | 10 |
against canine visceral | 10 |
the reaction was | 10 |
immunization of mice | 10 |
against rabies virus | 10 |
subjects in the | 10 |
antibody response was | 10 |
viral replication and | 10 |
large numbers of | 10 |
to the sars | 10 |
a subset of | 10 |
and the potential | 10 |
role of complement | 10 |
chadox mers with | 10 |
vaccines are available | 10 |
was significantly lower | 10 |
resulting in the | 10 |
in health care | 10 |
difference in the | 10 |
a mixture of | 10 |
show that the | 10 |
of the coronavirus | 10 |
was expressed as | 10 |
epitopes of the | 10 |
the cattery cats | 10 |
we did not | 10 |
three groups of | 10 |
proteins of avian | 10 |
responses and protection | 10 |
in clinical development | 10 |
in the number | 10 |
host range and | 10 |
i and ii | 10 |
to produce the | 10 |
collected from the | 10 |
phase i clinical | 10 |
s protein of | 10 |
effectiveness of influenza | 10 |
prescribing information and | 10 |
the threat of | 10 |
differences were observed | 10 |
have been tested | 10 |
pulmonary viral titer | 10 |
against rsv subgroup | 10 |
of our study | 10 |
has been developed | 10 |
change in the | 10 |
immunogenicity and efficacy | 10 |
n and n | 10 |
shown that the | 10 |
of adverse events | 10 |
for influenza vaccination | 10 |
the virus in | 10 |
in phase i | 10 |
possible that the | 10 |
the inclusion of | 10 |
vaccine group and | 10 |
with l of | 10 |
as the mean | 10 |
the influenza season | 10 |
spf eggs were | 10 |
t cells from | 10 |
response to influenza | 10 |
specific memory t | 10 |
implications for the | 10 |
different age groups | 10 |
develop a vaccine | 10 |
t cells was | 10 |
on the cell | 10 |
guangzhou and hong | 10 |
and the vaccine | 10 |
immunization with a | 10 |
s protein is | 10 |
diseases such as | 10 |
i ifn signaling | 10 |
gene expression in | 10 |
and patient information | 10 |
is critical for | 10 |
to define the | 10 |
effect on the | 10 |
vaccination of the | 10 |
in a recent | 10 |
of the vaccines | 10 |
of the inactivation | 10 |
of mycobacterium tuberculosis | 10 |
the observation period | 10 |
class i molecules | 10 |
noted that the | 10 |
provided by dr | 10 |
sequences of the | 10 |
the pbs control | 10 |
to have an | 10 |
major histocompatibility complex | 10 |
of the infected | 10 |
inoculated intranasally with | 10 |
not included in | 10 |
different doses of | 10 |
and protective immunity | 10 |
the online version | 10 |
expression in mammalian | 10 |
to replicate in | 10 |
united states and | 10 |
monoclonal antibodies against | 10 |
h at room | 10 |
were collected on | 10 |
in the incidence | 10 |
in human cells | 10 |
at mucosal sites | 10 |
in collaboration with | 10 |
a potent adjuvant | 10 |
coalition for epidemic | 10 |
is due to | 10 |
oral vaccination of | 10 |
access to vaccines | 10 |
days and post | 10 |
vaccines safety working | 10 |
in the form | 10 |
of diarrhoea and | 10 |
of the initial | 10 |
in spite of | 10 |
culture supernatants were | 10 |
the goal of | 10 |
the sera of | 10 |
mediated by the | 10 |
inoculated with the | 10 |
specific igg and | 10 |
the total number | 10 |
the other two | 10 |
we show that | 10 |
viral vector vaccine | 10 |
of the assay | 10 |
for up to | 10 |
be achieved by | 10 |
pcr assay for | 10 |
live attenuated influenza | 10 |
a vaccine clinical | 10 |
of protective immunity | 10 |
level of neutralizing | 10 |
a role for | 10 |
were serially diluted | 10 |
p vaccine candidate | 10 |
american indian alaska | 10 |
at the site | 10 |
the european union | 10 |
with a higher | 10 |
and hong kong | 10 |
the results obtained | 10 |
live and inactivated | 10 |
could be a | 10 |
the animals were | 10 |
of the m | 10 |
a and c | 10 |
and modified vaccinia | 10 |
induction of protective | 10 |
well as a | 10 |
were inoculated by | 10 |
the department of | 10 |
of the potential | 10 |
mutations in the | 10 |
fact that the | 10 |
to porcine reproductive | 10 |
washed three times | 10 |
influenza vaccination among | 10 |
in protection against | 10 |
h and h | 10 |
amino acid sequences | 10 |
been demonstrated to | 10 |
surface of the | 10 |
on the use | 10 |
is shown in | 10 |
of the h | 10 |
of c b | 10 |
and n proteins | 10 |
defined as the | 10 |
of viral rna | 10 |
antibody response against | 10 |
is thought to | 10 |
are able to | 10 |
of rift valley | 10 |
an influenza vaccine | 10 |
the viral genome | 10 |
in dromedary camels | 10 |
of the vaccination | 10 |
intending to take | 10 |
not significantly different | 10 |
some of these | 10 |
final concentration of | 10 |
the cell surface | 10 |
which could be | 10 |
of the host | 10 |
vaccines that are | 10 |
of the serum | 10 |
were approved by | 10 |
immune response by | 10 |
similar results were | 9 |
vaccine in healthy | 9 |
virus infection of | 9 |
of antigenic sites | 9 |
should be considered | 9 |
in europe and | 9 |
revealed that the | 9 |
of the live | 9 |
groups that received | 9 |
in the years | 9 |
burden of disease | 9 |
mouth disease in | 9 |
infection in humans | 9 |
pay for a | 9 |
exon splicing enhancers | 9 |
occurred in the | 9 |
protection against challenge | 9 |
of five mice | 9 |
of vesicular stomatitis | 9 |
of interest to | 9 |
number of animals | 9 |
was seen in | 9 |
used to evaluate | 9 |
for influenza vaccines | 9 |
human monoclonal antibodies | 9 |
nasal delivery of | 9 |
clinical development of | 9 |
myxomatosis and rabbit | 9 |
the differences between | 9 |
not yet been | 9 |
and the use | 9 |
those in the | 9 |
the st century | 9 |
ibv vaccinated groups | 9 |
the purified rha | 9 |
for collection of | 9 |
in the treatment | 9 |
were also found | 9 |
no significant difference | 9 |
it is estimated | 9 |
indian alaska native | 9 |
in the south | 9 |
the virus suspension | 9 |
animals to humans | 9 |
one of these | 9 |
in pig lungs | 9 |
higher than in | 9 |
were taken from | 9 |
and b malaysia | 9 |
for many years | 9 |
it was found | 9 |
clarified by centrifugation | 9 |
reversion to virulence | 9 |
in the next | 9 |
studies suggest that | 9 |
of these viruses | 9 |
of animal diseases | 9 |
in countries with | 9 |
from the national | 9 |
in conjunction with | 9 |
divided by the | 9 |
when compared with | 9 |
should also be | 9 |
pneumococcal conjugate vaccine | 9 |
old female balb | 9 |
we have demonstrated | 9 |
systematic review of | 9 |
the replication of | 9 |
and specificity of | 9 |
did not increase | 9 |
followed by incubation | 9 |
was a significant | 9 |
in severe acute | 9 |
of the manuscript | 9 |
was also observed | 9 |
haemorrhagic disease virus | 9 |
were mixed with | 9 |
are grateful to | 9 |
of one or | 9 |
for the evaluation | 9 |
time pcr assay | 9 |
th and th | 9 |
and to a | 9 |
level of protection | 9 |
of the wnv | 9 |
no evidence of | 9 |
public health impact | 9 |
cause of severe | 9 |
of up to | 9 |
pandemic h n | 9 |
virus is a | 9 |
analysis showed that | 9 |
be detected in | 9 |
in the lung | 9 |
the s tr | 9 |
the virus to | 9 |
large number of | 9 |
concentration of the | 9 |
mucosal immune responses | 9 |
is a determinant | 9 |
tested positive for | 9 |
for pandemic influenza | 9 |
and influenza virus | 9 |
the intranasal route | 9 |
supernatants were collected | 9 |
this study were | 9 |
of human disease | 9 |
in the virus | 9 |
is necessary to | 9 |
humoral and cell | 9 |
dilutions of the | 9 |
for induction of | 9 |
are those of | 9 |
data associated with | 9 |
iga and igm | 9 |
and mucosal immunity | 9 |
nucleocapsid protein of | 9 |
infections in the | 9 |
reported to be | 9 |
human monoclonal antibody | 9 |
binding to the | 9 |
of disease in | 9 |
of avian coronavirus | 9 |
the creation of | 9 |
titer was determined | 9 |
the n peptide | 9 |
the study of | 9 |
under field conditions | 9 |
variation in the | 9 |
those who are | 9 |
animals in the | 9 |
immune responses that | 9 |
is believed to | 9 |
of protection against | 9 |
health of the | 9 |
the health of | 9 |
the mechanism of | 9 |
did not differ | 9 |
as negative control | 9 |
of which are | 9 |
of the protein | 9 |
sensitivity and specificity | 9 |
viruses and their | 9 |
an immune response | 9 |
advances in the | 9 |
even in the | 9 |
health resources and | 9 |
rn protein formulated | 9 |
leading cause of | 9 |
of vaccination against | 9 |
and cellular immunity | 9 |
of an effective | 9 |
the work of | 9 |
in the general | 9 |
diseases in the | 9 |
of a rtv | 9 |
to this article | 9 |
a source of | 9 |
as early as | 9 |
chitosan and its | 9 |
relative to the | 9 |
the genome of | 9 |
efficacy and effectiveness | 9 |
protein of severe | 9 |
sars vaccine was | 9 |
colleagues intending to | 9 |
in some cases | 9 |
corresponding to residues | 9 |
the highest antibody | 9 |
discrete choice experiment | 9 |
of the ifn | 9 |
be included in | 9 |
receptor binding domain | 9 |
m and g | 9 |
may be due | 9 |
based vaccine candidates | 9 |
are presented in | 9 |
result in the | 9 |
as determined by | 9 |
at least two | 9 |
for production of | 9 |
of the other | 9 |
there may be | 9 |
pigs inoculated with | 9 |
the cellular immune | 9 |
for clinical signs | 9 |
infection of the | 9 |
to the control | 9 |
be safe and | 9 |
cost of the | 9 |
in the faeces | 9 |
all of these | 9 |
the properties of | 9 |
viral and bacterial | 9 |
an influenza pandemic | 9 |
seems to be | 9 |
expanded programme on | 9 |
to influenza vaccination | 9 |
been tested in | 9 |
higher than those | 9 |
used in a | 9 |
the first immunization | 9 |
or mvaik rsv | 9 |
with this article | 9 |
were defined as | 9 |
protection against a | 9 |
replication in the | 9 |
resulted in an | 9 |
in viral titer | 9 |
pfu ml in | 9 |
global burden of | 9 |
the rate of | 9 |
recombinant measles virus | 9 |
the changes in | 9 |
recombinant vaccinia viruses | 9 |
vaccination and the | 9 |
was based on | 9 |
with the highest | 9 |
and in vitro | 9 |
with g ml | 9 |
because it is | 9 |
of more than | 9 |
had the lowest | 9 |
as vaccine vectors | 9 |
by using the | 9 |
truncated g protein | 9 |
measles vaccine expressing | 9 |
to develop an | 9 |
analysis of variance | 9 |
infection with the | 9 |
to bordetella pertussis | 9 |
virus was detected | 9 |
challenged with the | 9 |
and services administration | 9 |
pbs control group | 9 |
antibody in the | 9 |
old spf chickens | 9 |
and risk factors | 9 |
against sars cov | 9 |
we used the | 9 |
be difficult to | 9 |
this is in | 9 |
days after challenge | 9 |
of the antibodies | 9 |
an outbreak of | 9 |
the experimental group | 9 |
and effectiveness of | 9 |
an analysis of | 9 |
the specific igy | 9 |
low and middle | 9 |
vaccine candidates were | 9 |
risk benefit assessment | 9 |
s protein was | 9 |
were conducted in | 9 |
human igg fc | 9 |
smallpox vaccine in | 9 |
number of vaccines | 9 |
of the complement | 9 |
a vaccine is | 9 |
cloned mdck cells | 9 |
than the placebo | 9 |
serum samples from | 9 |
in these animals | 9 |
inoculated with p | 9 |
in the poultry | 9 |
a cohort of | 9 |
was incubated with | 9 |
s yz strain | 9 |
of the beaudette | 9 |
derived from a | 9 |
been reported in | 9 |
demonstrates that the | 9 |
strain in the | 9 |
in the final | 9 |
monoclonal antibodies to | 9 |
day and day | 9 |
there are no | 9 |
after a single | 9 |
rather than the | 9 |
of pertussis in | 9 |
as a live | 9 |
bronchitis virus strain | 9 |
higher levels of | 9 |
and avian influenza | 9 |
be explained by | 9 |
field strains of | 9 |
the chicks were | 9 |
in a clinical | 9 |
for diagnosis of | 9 |
a combination of | 9 |
were observed daily | 9 |
in west africa | 9 |
h n pdm | 9 |
isolated from a | 9 |
were performed with | 9 |
a comparison of | 9 |
it is worth | 9 |
significant difference at | 9 |
c measles vaccine | 9 |
based tgev vaccine | 9 |
strand rna viruses | 9 |
and field strains | 9 |
by the us | 9 |
the advisory committee | 9 |
when the vaccine | 9 |
that had received | 9 |
and l of | 9 |
duration of the | 9 |
in mdck cells | 9 |
of the th | 9 |
study showed that | 9 |
with and without | 9 |
rsv subgroup b | 9 |
dose of vaccine | 9 |
found to have | 9 |
correlates of immunity | 9 |
on immunization practices | 9 |
resources and services | 9 |
test was used | 9 |
periods with elevated | 9 |
kindly provided by | 9 |
genbank accession number | 9 |
were detected at | 9 |
for the expression | 9 |
the transmission of | 9 |
significantly associated with | 9 |
play a role | 9 |
of the data | 9 |
response in mice | 9 |
vaccines in the | 9 |
the population of | 9 |
cells and the | 9 |
for influenza virus | 9 |
than that in | 9 |
s gene of | 9 |
after the second | 9 |
the immune responses | 9 |
neutralizing antibody levels | 9 |
that received the | 9 |
the human mhc | 9 |
or f protein | 9 |
of yellow fever | 9 |
specific t cell | 9 |
wild rabbit populations | 9 |
of the four | 9 |
has been described | 9 |
during the period | 9 |
oral bait vaccine | 9 |
years and older | 9 |
in the non | 9 |
assay for the | 9 |
was found that | 9 |
disease burden in | 9 |
be considered as | 9 |
four groups of | 9 |
the vaccine virus | 9 |
structural proteins of | 9 |
as the reciprocal | 9 |
supplementary data associated | 9 |
protection of the | 9 |
for the purpose | 9 |
the degree of | 9 |
specific pathogen free | 9 |
the neutralization titer | 9 |
and challenged with | 9 |
cho cell line | 9 |
by means of | 9 |
were similar to | 9 |
the human immunodeficiency | 9 |
were purchased from | 9 |
of the highest | 9 |
be an important | 9 |
the titer of | 9 |
and the other | 9 |
was treated with | 9 |
during the pandemic | 9 |
but did not | 9 |
g or vsv | 9 |
used to determine | 9 |
n and h | 9 |
each age group | 9 |
immune system to | 9 |
the e glycoprotein | 9 |
ibv and ampv | 9 |
protection against the | 9 |
system for the | 9 |
mm sodium phosphate | 9 |
domain of the | 9 |
nt antibodies against | 9 |
do not have | 9 |
with the recombinant | 9 |
on the s | 9 |
replication of the | 9 |
the adjuvanticity of | 9 |
to better understand | 9 |
of the control | 9 |
among healthcare workers | 9 |
from lymph nodes | 9 |
in a large | 9 |
linked to the | 9 |
of the aik | 9 |
the change in | 9 |
there are many | 9 |
and use committee | 9 |
acute phase proteins | 9 |
was similar to | 9 |
in ovo vaccination | 9 |
neutralizing antibody and | 9 |
to respond to | 9 |
in this trial | 9 |
the pathogenicity of | 9 |
of inactivated influenza | 9 |
as a potential | 9 |
protein of sars | 9 |
of the gene | 9 |
of zika virus | 9 |
local and systemic | 9 |
period of time | 9 |
a safe and | 9 |
was confirmed by | 9 |
vaccinated with a | 9 |
the protection of | 9 |
get vaccinated against | 9 |
by western blot | 9 |
of a high | 9 |
acellular pertussis vaccines | 9 |
vaccines can be | 9 |
divided into three | 9 |
were unable to | 9 |
of the rbd | 9 |
t cell epitope | 9 |
proteins in the | 9 |
which can be | 9 |
type of immune | 9 |
eid of the | 8 |
among health care | 8 |
are responsible for | 8 |
the range of | 8 |
an increased frequency | 8 |
lc m and | 8 |
genetically modified l | 8 |
phase iii trials | 8 |
infectious virus was | 8 |
from patients with | 8 |
dna vaccine encoding | 8 |
kong and singapore | 8 |
in part by | 8 |
used to describe | 8 |
infectious diseases with | 8 |
were seen in | 8 |
an inactivated vaccine | 8 |
for the construction | 8 |
vaccine expressing the | 8 |
mutation in the | 8 |
in the eu | 8 |
mediated immune responses | 8 |
by pcr using | 8 |
immune responses induced | 8 |
that does not | 8 |
in a phase | 8 |
human clinical trials | 8 |
data demonstrate that | 8 |
with hepatitis b | 8 |
or in combination | 8 |
there are still | 8 |
commercial broiler chicks | 8 |
older adults and | 8 |
epidemic preparedness innovations | 8 |
fold higher than | 8 |
divided into four | 8 |
and did not | 8 |
in the ibv | 8 |
been developed by | 8 |
were stimulated with | 8 |
vaccine prepared from | 8 |
were derived from | 8 |
with the rh | 8 |
of vaccine candidates | 8 |
influenza vaccine production | 8 |
was detected by | 8 |
an attempt to | 8 |